Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Wong

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|July 22, 2009
RCP is a human breast cancer-promoting gene with Ras-activating functionJinqiu Zhang, Xuejing Liu, Arpita Datta, et al.
The Journal of Infectious Diseases|November 29, 2020
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BJie Li, Hwai-I Yang, Ming-Lun Yeh, et al.
Hepatology (Baltimore, Md.)|March 11, 2025
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence predictionP Jonathan Li, Parissa Tabrizian, Darine Daher, et al.
JACC. Cardiovascular Imaging|May 23, 2021
Mechanisms Underlying the Association of Chronic Obstructive Pulmonary Disease With Heart FailureJakub Lagan, Erik B Schelbert, Josephine H Naish, et al.
Journal of Medicinal Chemistry|December 23, 2016
Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-ArylaminopurinesChristopher R Coxon, Elizabeth Anscombe, Suzannah J Harnor, et al.
The American Journal of Gastroenterology|October 22, 2019
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis BYao-Chun Hsu, Grace Lai-Hung Wong, Chien-Hung Chen, et al.
The Journal of Infectious Diseases|September 25, 2019
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral TherapyHwai-I Yang, Ming-Lun Yeh, Grace L Wong, et al.
Plos One|November 9, 2018
Recovery planning towards doubling wild tiger Panthera tigris numbers: Detailing 18 recovery sites from across the rangeAbishek Harihar, Pranav Chanchani, Jimmy Borah, et al.
Hepatology International|January 4, 2021
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patientsMatt Liu, Tai-Chung Tseng, Dae Won Jun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2021
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision MedicineJiyoon Park, An K Le, Tai-Chung Tseng, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|July 22, 2009
RCP is a human breast cancer-promoting gene with Ras-activating functionJinqiu Zhang, Xuejing Liu, Arpita Datta, et al.
The Journal of Infectious Diseases|November 29, 2020
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BJie Li, Hwai-I Yang, Ming-Lun Yeh, et al.
Hepatology (Baltimore, Md.)|March 11, 2025
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence predictionP Jonathan Li, Parissa Tabrizian, Darine Daher, et al.
JACC. Cardiovascular Imaging|May 23, 2021
Mechanisms Underlying the Association of Chronic Obstructive Pulmonary Disease With Heart FailureJakub Lagan, Erik B Schelbert, Josephine H Naish, et al.
Journal of Medicinal Chemistry|December 23, 2016
Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-ArylaminopurinesChristopher R Coxon, Elizabeth Anscombe, Suzannah J Harnor, et al.
The American Journal of Gastroenterology|October 22, 2019
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis BYao-Chun Hsu, Grace Lai-Hung Wong, Chien-Hung Chen, et al.
The Journal of Infectious Diseases|September 25, 2019
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral TherapyHwai-I Yang, Ming-Lun Yeh, Grace L Wong, et al.
Plos One|November 9, 2018
Recovery planning towards doubling wild tiger Panthera tigris numbers: Detailing 18 recovery sites from across the rangeAbishek Harihar, Pranav Chanchani, Jimmy Borah, et al.
Hepatology International|January 4, 2021
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patientsMatt Liu, Tai-Chung Tseng, Dae Won Jun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2021
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision MedicineJiyoon Park, An K Le, Tai-Chung Tseng, et al.
Pageof 14